Asztma: vizsgálatok itt: Argentína
19 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
- Where
- CABA, Mendoza, Rosario
- Életkor
- 6 év to 11 év
- People
- 200 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05562466 · EU 2022-501899-26-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
- Where
- Rosario
- Életkor
- 12 év to 17 év
- People
- 188 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05776927 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- Where
- Buenos Aires, CABA, Florida, Lanus, Lobos, Mendoza, Quilmes, Rosario
- Életkor
- 5 év to 11 év
- People
- 231 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06023589 - 3. fázisTaking peopleRoll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
- Where
- Buenos Aires, Florida, Lobos, Mar del Plata, Mendoza, Rosario, San Juan Bautista
- Életkor
- 6 év and over
- People
- 230 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07444567 - 2. fázisTaking peopleA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Where
- Buenos Aires, Ciudad Autonoma de Buenos Aires, Mar del Plata, Mendoza, Rosario, San Miguel de Tucumán
- Életkor
- 18 év to 75 év
- People
- 252 worldwide
- Run by
- Pfizer
See details and how to joinNCT06977581 · EU 2024-517866-40-00 - 2. fázisTaking peopleA Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- Where
- Buenos Aires, Ciudad de Buenos Aires, Corrientes, Granadero Baigorria, Mar del Plata, Río Cuarto, Rosario, Santa Fe
- Életkor
- 18 év to 75 év
- People
- 531 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07219173 - 3. fázisTaking peopleA Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
- Where
- Buenos Aires, Ciudad Autonoma de Buenos Aire, Lujan de Cuyo
- Életkor
- 18 év and over
- People
- 110 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07645248 - 3. fázisTaking peopleA Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
- Where
- Buenos Aires, Ciudad Autónoma de Buenos Aires, Concepción del Uruguay, Mar del Plata, Mendoza, Rosario, San Miguel de Tucumán, San Salvador, Santa Fe
- Életkor
- 12 év to 80 év
- People
- 786 worldwide
- Run by
- Generate Biomedicines
See details and how to joinNCT07359846 - 2. fázisTaking peopleA Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma
- Where
- Buenos Aires, Córdoba, Mendoza, Rosario, Santa Fe
- Életkor
- 18 év to 85 év
- People
- 440 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07746687 · EU 2026-526262-24-00 - 2. fázisTaking peopleDose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Where
- CABA, Ciudad de Buenos Aires, La Plata, Mendoza, Rosario, San Miguel de Tucumán
- Életkor
- 18 év to 75 év
- People
- 540 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06932263 · EU 2024-519116-14-00 - 2. fázisTaking peopleStudy to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma
- Where
- Buenos Aires, Córdoba, Paraná, Rosario, San Miguel de Tucumán, Santa Fe
- Életkor
- 18 év to 75 év
- People
- 600 worldwide
- Run by
- Windward Bio
See details and how to joinNCT07120503 · EU 2025-521391-58-00 - No phaseTaking peopleAssess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis
- Where
- Buenos Aires, Medoza
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07245576 - 2. fázisTaking peopleA Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Where
- Buenos Aires, CABA, Lanús Este, La Plata, Lobos, Mar del Plata, Mendoza, Rosario, San Juan Bautista, Santa Fe
- Életkor
- 4 év to 11 év
- People
- 69 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07525375 · EU 2025-524914-26-00 - 2. fázisTaking peopleA Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
- Where
- Buenos Aires, Concepción del Uruguay, Lobos, Mar del Plata, Quilmes, Rosario, San Miguel de Tucumán
- Életkor
- 18 év to 75 év
- People
- 264 worldwide
- Run by
- Kymera Therapeutics, Inc.
See details and how to joinNCT07323654 - 2. fázisCsak meghívásosLong-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
- Where
- Berazategui, Buenos Aires, La Plata, Buenos Aires, Lobos, Mendoza, Rosario, San Miguel de Tucumán, Santa Fe
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00 - 3. fázisCsak meghívásosEfficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
- Where
- Buenos Aires, Córdoba, Corrientes, Mendoza, Rosario
- Életkor
- 2 év to 5 év
- People
- 90 worldwide
- Run by
- Sanofi
See details and how to joinNCT06191315 · EU 2023-504331-41-00 - 2. fázisTaking peopleTherapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
- Where
- Buenos Aires, Ciudad Autonoma de Buenos Aire, Córdoba, La Plata, Mendoza, Quilmes, Rosario, San Juan Bautista, San Miguel de Tucumán, Santa Fe
- Életkor
- 18 év to 75 év
- People
- 780 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07301736 · EU 2025-521456-35-00 - 3. fázisTaking peopleEfficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
- Where
- Buenos Aires, Nueve de Julio, Rosario
- Életkor
- 12 év to 65 év
- People
- 736 worldwide
- Run by
- Inmunotek S.L.
See details and how to joinNCT07348302 - 2/3. fázisNot yet taking people in ArgentínaClinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract
- Where
- Buenos Aires
- Életkor
- 12 év to 60 év
- People
- 90
- Run by
- Inmunotek S.L.
See details and how to joinNCT05641272